Selected research
Market Structure
Global Sonidegib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sonidegib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sonidegib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sonidegib include Sun Pharmaceutical Industries and Novartis among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sonidegib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sonidegib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sonidegib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sonidegib market size, projected growth trends, production technologies, key applications, and end-use industries.
Sonidegib Segment by Company
Sun Pharmaceutical Industries
Novartis
Sonidegib Segment by Type
Solution
Capsule
Sonidegib Segment by Application
Treating Basal Cell Carcinoma
Antitumor
Others
Sonidegib Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sonidegib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sonidegib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sonidegib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sonidegib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sonidegib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sonidegib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sonidegib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Solution
- Capsule
Applications
- Treating Basal Cell Carcinoma
- Antitumor
- Others
Companies covered
- Sun Pharmaceutical Industries
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sonidegib Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sonidegib Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sonidegib Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sonidegib Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sonidegib Market Dynamics
- 2.1 Sonidegib Industry Trends
- 2.2 Sonidegib Industry Drivers
- 2.3 Sonidegib Industry Opportunities and Challenges
- 2.4 Sonidegib Industry Restraints
3 Sonidegib Market by Manufacturers
- 3.1 Global Sonidegib Revenue by Manufacturers (2021-2026)
- 3.2 Global Sonidegib Sales by Manufacturers (2021-2026)
- 3.3 Global Sonidegib Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sonidegib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sonidegib Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sonidegib Manufacturers, Product Type & Application
- 3.7 Global Sonidegib Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sonidegib Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sonidegib Players Market Share by Revenue in 2025
- 3.8.3 2025 Sonidegib Tier 1, Tier 2, and Tier 3
4 Sonidegib Market by Type
- 4.1 Sonidegib Type Introduction
- 4.1.1 Solution
- 4.1.2 Capsule
- 4.2 Global Sonidegib Sales by Type
- 4.2.1 Global Sonidegib Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sonidegib Sales by Type (2021-2032)
- 4.2.3 Global Sonidegib Sales Market Share by Type (2021-2032)
- 4.3 Global Sonidegib Revenue by Type
- 4.3.1 Global Sonidegib Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sonidegib Revenue by Type (2021-2032)
- 4.3.3 Global Sonidegib Revenue Market Share by Type (2021-2032)
5 Sonidegib Market by Application
- 5.1 Sonidegib Application Introduction
- 5.1.1 Treating Basal Cell Carcinoma
- 5.1.2 Antitumor
- 5.1.3 Others
- 5.2 Global Sonidegib Sales by Application
- 5.2.1 Global Sonidegib Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sonidegib Sales by Application (2021-2032)
- 5.2.3 Global Sonidegib Sales Market Share by Application (2021-2032)
- 5.3 Global Sonidegib Revenue by Application
- 5.3.1 Global Sonidegib Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sonidegib Revenue by Application (2021-2032)
- 5.3.3 Global Sonidegib Revenue Market Share by Application (2021-2032)
6 Global Sonidegib Sales by Region
- 6.1 Global Sonidegib Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sonidegib Sales by Region (2021-2032)
- 6.2.1 Global Sonidegib Sales by Region (2021-2026)
- 6.2.2 Global Sonidegib Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sonidegib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sonidegib Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sonidegib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sonidegib Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sonidegib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sonidegib Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sonidegib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sonidegib Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sonidegib Revenue by Region
- 7.1 Global Sonidegib Revenue by Region
- 7.1.1 Global Sonidegib Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sonidegib Revenue by Region (2021-2026)
- 7.1.3 Global Sonidegib Revenue by Region (2027-2032)
- 7.1.4 Global Sonidegib Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sonidegib Revenue (2021-2032)
- 7.2.2 North America Sonidegib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sonidegib Revenue (2021-2032)
- 7.3.2 Europe Sonidegib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sonidegib Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sonidegib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sonidegib Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sonidegib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical Industries
- 8.1.1 Sun Pharmaceutical Industries Company Information
- 8.1.2 Sun Pharmaceutical Industries Business Overview
- 8.1.3 Sun Pharmaceutical Industries Sonidegib Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Industries Sonidegib Product Portfolio
- 8.1.5 Sun Pharmaceutical Industries Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Sonidegib Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Sonidegib Product Portfolio
- 8.2.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sonidegib Value Chain Analysis
- 9.1.1 Sonidegib Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sonidegib Production Mode & Process
- 9.2 Sonidegib Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sonidegib Distributors
- 9.2.3 Sonidegib Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst